Breast cancer is one of the most common causes of deaths worldwide. Major obstacles to treatment have contributed to the increasing popularity of complementary or alternative therapies. Although recent results support the mechanism that honey induces cell death, the full mechanisms are still unknown. This study investigates the potential use of Pervari honey (PH) as an in vitro therapeutic agent in breast cancer. Firstly, the antioxidant capacity and total phenolic content of PH were tested. In addition, MCF-7 and MDA-MB-231 breast cancer cells treated with PH were examined for cell viability, reactive oxygen species production, oxidative deoxyribonucleic acid (DNA) damage, and apoptosis. Our results show that PH treatment decreased cell viability dose-dependently and increased reactive oxygen species (ROS) levels, oxidative DNA damage, and apoptosis rate. The present study suggests that honey is a promising source to produce pharmaceuticals and nutraceuticals for breast cancer therapy.
Antioxidant apoptosis cancer honey oxidative deoxyribonucleic acid (DNA) damage reactive oxygen species
Primary Language | English |
---|---|
Subjects | Cell Development, Proliferation and Death, Cancer Biology |
Journal Section | Research Article |
Authors | |
Publication Date | September 30, 2024 |
Submission Date | March 21, 2024 |
Acceptance Date | July 8, 2024 |
Published in Issue | Year 2024 |
As of 2024, JARNAS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC).